CD25-SPECIFIC ANTIBODIES AND USES THEREOF
Technology
E-129-2022
Patent ID
E-129-2022-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/357,215
IC
NCI
Date Filed
Date Issued
Patent PDF